These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19187487)

  • 1. Time-dose-response models for microbial risk assessment.
    Huang Y; Haas CN
    Risk Anal; 2009 May; 29(5):648-61. PubMed ID: 19187487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating time postinoculation into a dose-response model of Yersinia pestis in mice.
    Huang Y; Bartrand TA; Haas CN; Weir MH
    J Appl Microbiol; 2009 Sep; 107(3):727-35. PubMed ID: 19302316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative microbial risk assessment model for Legionnaires' disease: animal model selection and dose-response modeling.
    Armstrong TW; Haas CN
    Risk Anal; 2007 Dec; 27(6):1581-96. PubMed ID: 18093054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk/benefit assessments of human diseases: optimum dose for intervention.
    Gaylor DW
    Risk Anal; 2005 Feb; 25(1):161-8. PubMed ID: 15787765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A probabilistic framework for non-cancer risk assessment.
    Chen JJ; Moon H; Kodell RL
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):45-50. PubMed ID: 17166641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal and human dose-response models for Brucella species.
    Teske SS; Huang Y; Tamrakar SB; Bartrand TA; Weir MH; Haas CN
    Risk Anal; 2011 Oct; 31(10):1576-96. PubMed ID: 21449960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causation in risk assessment and management: models, inference, biases, and a microbial risk-benefit case study.
    Cox LA; Ricci PF
    Environ Int; 2005 Apr; 31(3):377-97. PubMed ID: 15734191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model averaging using the Kullback information criterion in estimating effective doses for microbial infection and illness.
    Moon H; Kim HJ; Chen JJ; Kodell RL
    Risk Anal; 2005 Oct; 25(5):1147-59. PubMed ID: 16297221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of improved air quality on mortality risks in Erfurt, Germany.
    Peters A; Breitner S; Cyrys J; Stölzel M; Pitz M; Wölke G; Heinrich J; Kreyling W; Küchenhoff H; Wichmann HE
    Res Rep Health Eff Inst; 2009 Feb; (137):5-77; discussion 79-90. PubMed ID: 19554968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model averaging in microbial risk assessment using fractional polynomials.
    Namata H; Aerts M; Faes C; Teunis P
    Risk Anal; 2008 Aug; 28(4):891-905. PubMed ID: 18564995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative methods of cancer risk assessment in exposure to chemicals].
    Szymczak W
    Med Pr; 2009; 60(3):215-21. PubMed ID: 19746890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment.
    Small MJ
    Risk Anal; 2008 Oct; 28(5):1289-308. PubMed ID: 18844862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-target models and their application to data analysis of cellular mortality due to radiation exposure.
    Arcana IM; Ohtaki M
    Hiroshima J Med Sci; 2005 Mar; 54(1):9-20. PubMed ID: 15847060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative risk assessment for developmental neurotoxic effects.
    Razzaghi M; Kodell R
    Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression models for mixed Poisson and continuous longitudinal data.
    Yang Y; Kang J; Mao K; Zhang J
    Stat Med; 2007 Sep; 26(20):3782-800. PubMed ID: 17133630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response models for inhalation of Bacillus anthracis spores: interspecies comparisons.
    Bartrand TA; Weir MH; Haas CN
    Risk Anal; 2008 Aug; 28(4):1115-24. PubMed ID: 18554269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of risk assessment and likelihood estimation to analyze spatial distribution pattern of respiratory infection cases.
    Sze-To GN; Chao CY
    Risk Anal; 2011 Mar; 31(3):351-69. PubMed ID: 21039710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.